In line with this, the identification of genetic lesions in human cancers [7,8,9], together with the use of genetically engineered mouse models [10,11] that lead to both these states, provided convincing evidence supporting an important role for members of the BCL-2 family in cancer. The gene discussed is BCL2; the disease is cancer.